Mirum Pharmaceuticals Ownership | Who Owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals Ownership Summary
Mirum Pharmaceuticals is owned by 111.04% institutional investors, 2.24% insiders. Frazier life sciences management is the largest institutional shareholder, holding 13.84% of MIRM shares. Eventide Gilead N is the top mutual fund, with 3.69% of its assets in Mirum Pharmaceuticals shares.
MIRM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mirum Pharmaceuticals | 111.04% | 2.24% | -13.28% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 6.50M | 13.84% | $222.08M |
| Janus henderson group | 4.99M | 10.63% | $170.56M |
| Bvf inc/il | 4.37M | 9.31% | $149.41M |
| Eventide asset management | 3.61M | 7.70% | $123.59M |
| Blackrock | 3.24M | 6.90% | $110.71M |
| Vanguard group | 2.45M | 5.21% | $83.65M |
| Rock springs capital management lp | 1.77M | 3.78% | $60.59M |
| Novo | 1.50M | 3.20% | $51.28M |
| State street | 1.50M | 3.19% | $51.16M |
| Tang capital management | 1.29M | 2.74% | $44.01M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Frazier life sciences management | 6.50M | 10.39% | $222.08M |
| Boone capital management | 523.68K | 4.67% | $17.90M |
| Tang capital management | 1.29M | 4.48% | $44.01M |
| Bvf inc/il | 4.37M | 4.19% | $149.41M |
| First turn management | 703.40K | 3.91% | $24.05M |
| Nan fung group | 106.10K | 3.87% | $3.63M |
| Prosight management, lp | 314.80K | 3.22% | $10.76M |
| Lion point capital, lp | 45.00K | 2.80% | $1.54M |
| Highlander partners | 122.98K | 2.80% | $4.20M |
| Bioimpact capital | 492.57K | 2.62% | $16.84M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 4.99M | 0.09% | 2.22M |
| Blackrock | 3.24M | 0.00% | 785.78K |
| Candriam s.c.a. | 508.48K | 0.11% | 508.48K |
| Bioimpact capital | 492.57K | 2.62% | 492.57K |
| Clearbridge investments | 699.93K | 0.02% | 436.35K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.50M | 0.00% | -1.33M |
| Cadian capital management, lp | 1.24M | 2.10% | -1.06M |
| William blair investment management | - | - | -677.94K |
| Avidity partners management lp | 731.10K | 1.06% | -411.75K |
| Price t rowe associates inc /md/ | 1.20M | 0.00% | -398.29K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Candriam s.c.a. | 508.48K | 0.11% | 508.48K | $17.38M |
| Bioimpact capital | 492.57K | 2.62% | 492.57K | $16.84M |
| Pdt partners | 39.36K | 0.13% | 39.36K | $1.35M |
| Empowered funds | 33.27K | 0.02% | 33.27K | $1.38M |
| Schonfeld strategic advisors | 22.24K | 0.00% | 22.24K | $760.52K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Cibc private wealth group | -10.00 |
| Private wealth management group | -35.00 |
| Lazard asset management | -74.00 |
| Bear mountain capital | -100.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 184 | 11.52% | 53,056,700 | -0.10% | 111 | 0.87% | 114 | 25.27% | 40 | -20.00% |
| Jun 30, 2024 | 165 | -5.17% | 53,108,448 | -0.23% | 113 | 0.88% | 91 | -3.19% | 50 | -3.85% |
| Mar 31, 2024 | 174 | -8.42% | 53,228,863 | 6.43% | 113 | 0.99% | 94 | -18.97% | 52 | 1.96% |
| Dec 31, 2023 | 190 | 19.50% | 50,012,606 | 2.71% | 107 | 0.76% | 116 | 18.37% | 51 | 59.38% |
| Sep 30, 2023 | 159 | 8.16% | 48,693,333 | 31.20% | 118 | 1.25% | 98 | 1.03% | 32 | 14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Gilead N | 1.77M | 3.69% | - |
| Eventide Healthcare & Life Sciences I | 1.67M | 3.47% | -171.31K |
| Vanguard Total Stock Mkt Idx Inv | 1.30M | 2.71% | -116.02K |
| iShares Russell 2000 ETF | 1.06M | 2.21% | -4.08K |
| Janus Henderson Global Life Sciences | 825.72K | 1.73% | -133.32K |
| Janus Henderson Global Life Sciences D | 773.70K | 1.61% | -52.14K |
| T. Rowe Price New Horizons | 767.71K | 1.60% | - |
| US Small-Cap Growth II Equity Comp | 767.71K | 1.60% | -660.00 |
| MEDICAL BioHealth EUR Acc | 756.50K | 1.59% | - |
| Janus Henderson US SMID Cap Growth MA | 712.39K | 1.49% | 712.39K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 24, 2025 | Radovich Peter | PRESIDENT AND COO | Sell | $152.26K |
| Jan 24, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $43.23K |
| Jan 24, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | $327.66K |
| Jan 17, 2025 | Quan Joanne | CHIEF MEDICAL OFFICER | Sell | $319.60K |
| Jan 07, 2025 | Radovich Peter | PRESIDENT AND COO | Sell | $85.54K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | 2 | 1 |
| 2024 Q2 | - | 2 |
| 2024 Q1 | 2 | 11 |
| 2023 Q4 | 1 | 1 |
MIRM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools